A Cell-Permeant Peptide Corresponding to the cUBP Domain of USP5 Reverses Inflammatory and Neuropathic Pain

Molecular Pain - United Kingdom
doi 10.1177/1744806916642444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Spinal NTS2 Receptor Activation Reverses Signs of Neuropathic Pain

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2013English

Keratinocyte Expression of Calcitonin Gene-Related Peptide Β: Implications for Neuropathic and Inflammatory Pain Mechanisms

Pain
NeurologyAnesthesiologyPain MedicinePharmacology
2011English

A Brief Comparison of the Pathophysiology of Inflammatory Versus Neuropathic Pain

Current Opinion in Anaesthesiology
AnesthesiologyPain Medicine
2011English

Leukotrienes in Nociceptive Pathway and Neuropathic/Inflammatory Pain

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

Targeting Angiotensin II Type 2 Receptor Pathways to Treat Neuropathic Pain and Inflammatory Pain

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Amylin, a Peptide Expressed by Nociceptors, Modulates Chronic Neuropathic Pain

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2019English

A Novel Compound Targeting Kv7.2/3 Channels Relieves Inflammatory and Neuropathic Pain

Biophysical Journal
Biophysics
2014English

A Novel Model of Combined Neuropathic and Inflammatory Pain Displaying Long-Lasting Allodynia and Spontaneous Pain-Like Behaviour

Neuroscience Research
MedicineNeuroscience
2012English

Cannabinoids Suppress Inflammatory and Neuropathic Pain by Targeting Α3 Glycine Receptors

Journal of Experimental Medicine
MedicineAllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy